Blood pressure regulation involves integrated neural, hormonal, and local control mechanisms that maintain perfusion to vital organs. Short-term regulation occurs within seconds to minutes, while long-term regulation operates over hours to days.
Short-Term Regulation
Baroreceptor Reflex
The baroreceptor reflex is the most important short-term blood pressure regulation mechanism.
Anatomy:
| Component | Location | Structure |
|---|---|---|
| Arterial baroreceptors | Carotid sinus (internal carotid) | Stretch-sensitive nerve endings |
| Arterial baroreceptors | Aortic arch | Stretch-sensitive nerve endings |
| Low-pressure baroreceptors | Atria, pulmonary veins | Stretch receptors (volume sensors) |
| Afferent nerves | Glossopharyngeal (IX) - carotid sinus nerve | To medulla |
| Afferent nerves | Vagus (X) - aortic depressor nerve | To medulla |
| Integrating center | Medulla oblongata | NTS, nucleus ambiguus, CVLM, RVLM |
| Efferent nerves | Autonomic (sympathetic and parasympathetic) | To heart and vessels |
Mechanism:
- Increased BP → baroreceptor stretch → increased afferent firing
- Medullary integration:
- Increased NTS activation
- Increased vagal (parasympathetic) outflow
- Decreased sympathetic outflow
- Effector responses:
- Heart: Bradycardia, decreased contractility
- Vessels: Vasodilation (decreased SVR)
- Overall: BP decreases toward normal
Set point and resetting:
- Baroreceptors are most sensitive around normal MAP (90-100 mmHg)
- Chronic hypertension: Baroreceptors reset to higher pressure
- Resetting: Within 24-48 hours
Chemoreceptor Reflex
Anatomy:
- Central chemoreceptors: Medulla oblongata (respond to CO₂, pH)
- Peripheral chemoreceptors: Carotid and aortic bodies (respond to O₂, CO₂, pH)
Response to hypoxia:
| PO₂ | Response |
|---|---|
| 60-80 mmHg | Minimal stimulation |
| 40-60 mmHg | Moderate increase in ventilation and sympathetic tone |
| < 40 mmHg | Strong activation, vasoconstriction, bradycardia (diving reflex) |
Cushing Reflex
Response to increased intracranial pressure:
- Increased ICP compresses cerebral vessels
- Cerebral ischemia (medullary ischemia)
- Sympathetic storm (massive vasoconstriction)
- Increased BP (to overcome ICP)
- Reflex bradycardia (baroreceptor activation)
Cushing triad: Hypertension, bradycardia, irregular respirations
Intermediate-Term Regulation
Renin-Angiotensin-Aldosterone System (RAAS)
The RAAS is the most important intermediate and long-term regulatory system.
Components:
| Component | Source | Action |
|---|---|---|
| Renin | Juxtaglomerular cells (kidney) | Converts angiotensinogen to angiotensin I |
| Angiotensinogen | Liver | Substrate (inactive) |
| ACE | Endothelial cells (lung, kidney) | Converts angiotensin I to angiotensin II |
| Angiotensin II | Circulation | Potent vasoconstrictor, aldosterone release |
| Aldosterone | Adrenal cortex | Renal sodium and water retention |
Renin release stimuli:
| Stimulus | Mechanism |
|---|---|
| ↓ Renal perfusion pressure | Renal baroreceptor (juxtaglomerular cells) |
| ↓ NaCl delivery to macula densa | Tubuloglomerular feedback |
| β1-sympathetic activation | Direct neural stimulation |
| Prostaglandins (PGE2, PGI2) | Paracrine stimulation |
Angiotensin II effects:
| Effect | Mechanism | Time Course |
|---|---|---|
| Vasoconstriction | AT1 receptor on vascular smooth muscle | Seconds |
| Aldosterone release | Adrenal zona glomerulosa | Minutes |
| Sodium reabsorption | Proximal tubule (direct) | Minutes |
| Thirst stimulation | Subfornical organ, OVLT | Minutes |
| ADH release | Posterior pituitary | Minutes |
| Cardiac remodeling | Myocyte hypertrophy | Days to weeks |
| Renal fibrosis | TGF-β activation | Weeks to months |
Long-Term Regulation
Renal-Body Fluid Feedback
The kidney maintains long-term blood pressure by controlling blood volume:
Pressure-natriuresis relationship:
- Increased BP → increased sodium excretion → decreased volume → decreased BP
- Decreased BP → decreased sodium excretion → increased volume → increased BP
Infinite gain: The renal-body fluid feedback system has infinite gain (can return BP exactly to the set point)
Atrial Natriuretic Peptide (ANP)
| Source | Stimulus | Effects |
|---|---|---|
| Right atrium (stretch) | Increased atrial pressure | Natriuresis, vasodilation |
| Left atrium (stretch) | Increased atrial pressure | RAAS inhibition |
Vasopressin (ADH)
| Source | Stimulus | Effects |
|---|---|---|
| Posterior pituitary | Increased osmolality, decreased volume | Water retention, vasoconstriction (at high levels) |
Local Regulation
Myogenic Response
Vascular smooth muscle responds to stretch:
- Increased pressure → contraction (vasoconstriction)
- Decreased pressure → relaxation (vasodilation)
Metabolic Regulation
| Metabolite | Effect | Mechanism |
|---|---|---|
| Adenosine | Vasodilation | A2 receptors |
| CO₂ | Vasodilation (brain), constriction (lung) | pH-mediated |
| H⁺ | Vasodilation | pH-mediated |
| K⁺ | Vasodilation | Hyperpolarization |
| Lactate | Vasodilation | ?? |
| ↓ O₂ | Vasodilation | HIF, adenosine |
Flow-Mediated Dilation
Increased shear stress → endothelial NO synthase → NO → cGMP → relaxation
Endothelial Factors
| Factor | Effect |
|---|---|
| Nitric oxide (NO) | Vasodilation |
| Prostacyclin (PGI2) | Vasodilation |
| Endothelin-1 | Vasoconstriction |
| Thromboxane A2 | Vasoconstriction |
| EDHF | Vasodilation (hyperpolarization) |
Integrated Control
Response to Hemorrhage
| Time | Mechanism | Result |
|---|---|---|
| Seconds | Baroreceptor reflex | ↑ HR, ↑ SVR |
| Minutes | Chemoreceptor reflex | ↑ Ventilation, ↑ SVR |
| Minutes | RAAS activation | ↑ Angiotensin II, ↑ Aldosterone |
| Hours | ADH release | Water retention |
| Days | Thirst, renal conservation | Volume restoration |
| Weeks | Erythropoiesis | RBC mass restoration |
Response to Exercise
| Mechanism | Effect |
|---|---|
| Central command | ↑ Sympathetic, ↓ Parasympathetic |
| Muscle mechanoreflex | ↑ HR, ↑ BP |
| Muscle metaboreflex | ↑ Sympathetic (maintains BP) |
| Functional sympatholysis | Local vasodilation overrides sympathetic tone |
Age-Related Changes
| Change | Consequence |
|---|---|
| Baroreceptor sensitivity | Increased BP variability |
| Arterial stiffness | Increased SBP, widened PP |
| Reduced β-adrenergic response | Reduced maximal HR |
| Impaired endothelial function | Reduced NO bioavailability |
| RAAS activation changes | Altered sodium handling |
| Renal function decline | Impaired pressure-natriuresis |
Clinical Implications
Hypertension
| Mechanism | Role in HTN |
|---|---|
| Increased SVR | Primary abnormality in essential HTN |
| Sodium retention | Volume-dependent HTN |
| RAAS activation | Angiotensin II-mediated HTN |
| Sympathetic overactivity | Neurogenic HTN |
| Endothelial dysfunction | Impaired vasodilation |
Orthostatic Hypotension
Failure of compensatory mechanisms on standing:
- Baroreceptor dysfunction (aging, diabetes)
- Autonomic neuropathy
- Volume depletion
- Medications (alpha-blockers, diuretics)
Resistant Hypertension
Hypertension requiring ≥ 4 medications:
- Hyperaldosteronism (common cause)
- Renal artery stenosis
- Sleep apnea
- Medication non-adherence
- White coat effect